Morgan E. Obrien - Jun 15, 2022 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
Executive Chairman, Director
Signature
/s/ Gena L. Ashe, Attorney-in-Fact
Stock symbol
ATEX
Transactions as of
Jun 15, 2022
Transactions value $
-$375,775
Form type
4
Date filed
6/16/2022, 07:09 PM
Previous filing
Jun 1, 2022
Next filing
Aug 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATEX Common Stock Options Exercise $625K +25K +72.86% $25.00 59.3K Jun 15, 2022 Direct
transaction ATEX Common Stock Sale -$1M -25K -42.15% $40.03 34.3K Jun 15, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Options Exercise $0 -25K -21.74% $0.00 90K Jun 15, 2022 Common Stock 25K $25.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $40.00 to $40.595. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3 The option shares are fully vested.